Basic Information
BioNTech AG is a biopharmaceutical company developing personalized therapies for cancer and other diseases. The company leverages various computational discovery and therapeutic drug platforms to rapidly develop novel biologics. Based on its deep expertise in mRNA vaccine development and internal manufacturing capabilities, BioNTech and its collaborators are advancing multiple mRNA vaccine candidates for various infectious diseases through multiple oncology pathways.
BioNTech US Inc.
Mainz,Rheinland-Pfalz,Germany
more than 500 people
January 01, 2008
info@biontech.de
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios